Atomoxetine [clinicaltrials_resource:f6dfb98ca3654af73de96e2cdd47b28a]
Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD [clinicaltrials:NCT00029614]clinicaltrials:NCT00142961Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia [clinicaltrials:NCT00161031]clinicaltrials:NCT00167297Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar [clinicaltrials:NCT00174226]clinicaltrials:NCT00176436clinicaltrials:NCT00181766Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy [clinicaltrials:NCT00181948]clinicaltrials:NCT00183391clinicaltrials:NCT00190684Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months) [clinicaltrials:NCT00190736]clinicaltrials:NCT00190775Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder [clinicaltrials:NCT00190879]A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder [clinicaltrials:NCT00190931]Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse [clinicaltrials:NCT00190957]Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease [clinicaltrials:NCT00191009]Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD [clinicaltrials:NCT00191035]Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD [clinicaltrials:NCT00191048]Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00191295]clinicaltrials:NCT00191386An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder [clinicaltrials:NCT00191516]Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents [clinicaltrials:NCT00191542]Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes [clinicaltrials:NCT00191633]Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents [clinicaltrials:NCT00191659]Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD [clinicaltrials:NCT00191698]An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder [clinicaltrials:NCT00191737]Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder [clinicaltrials:NCT00191880]clinicaltrials:NCT00191906clinicaltrials:NCT00191945clinicaltrials:NCT00192023Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia [clinicaltrials:NCT00216281]Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder. [clinicaltrials:NCT00216918]Effectiveness of ATMX in Treating Adolescents With ADHD and SUD [clinicaltrials:NCT00218322]clinicaltrials:NCT00218543A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia [clinicaltrials:NCT00222794]clinicaltrials:NCT00223691Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents [clinicaltrials:NCT00252278]clinicaltrials:NCT00254462Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects [clinicaltrials:NCT00255138]clinicaltrials:NCT00260533
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Atomoxetine [clinicaltrials_resource:f6dfb98ca3654af73de96e2cdd47b28a]
Bio2RDF identifier
f6dfb98ca3654af73de96e2cdd47b28a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f6dfb98ca3654af73de96e2cdd47b28a
identifier
clinicaltrials_resource:f6dfb98ca3654af73de96e2cdd47b28a
title
Atomoxetine
@en
type
label
Atomoxetine [clinicaltrials_resource:f6dfb98ca3654af73de96e2cdd47b28a]
@en